Trulieve Cannabis, listed as TRLV, has been the subject of various analyses and reports. Some outlets have discussed the company's potential market share and investment narrative, including its expansion into Georgia and cost-cutting efforts. The stock's value has been debated, with some sources suggesting it may be overvalued, while others consider it potentially undervalued.